Tofacitinib in Juvenile Idiopathic Arthritis

ConditionJuvenile Idiopathic Arthritis (JIA)

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

AgeUp to 18

SponsorConsorci Sanitari de l'Alt Penedès i Garraf

About this trial

This study aims to evaluate, using real-world clinical practice data, the efficacy of tofacitinib in improving the clinical control of juvenile idiopathic arthritis (JIA) after 12 months of treatment.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Tofacitinib

Treatment groups

58 Participants

are divided into 1 treatment group

Sponsors and collaborators

Consorci Sanitari de l'Alt Penedès i Garraf

Lead sponsor

Source ClinicalTrials.gov